Pregabalin Treatment for Trigger Points

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 26, 2014

Primary Completion Date

July 26, 2014

Study Completion Date

January 26, 2015

Conditions
Myofascial Pain Syndrome
Interventions
DRUG

Pregabalin 150mg

"Patients in group I received pregabalin at a dose of 75 mg twice daily during the first week that was increased to 150 mg twice daily thereafter and maintained at that level for 12 weeks.~Patients in two groups received exercise therapy (stretching exercises for the trapezius muscle). Patients were instructed to perform 10 repetitions three times a day., 3 months"

Trial Locations (1)

34752

Fatih Sultan Mehmet Training and Research Hospital, Istanbul

All Listed Sponsors
lead

Fatih Sultan Mehmet Training and Research Hospital

OTHER

NCT04600037 - Pregabalin Treatment for Trigger Points | Biotech Hunter | Biotech Hunter